Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
36.36
+0.34
+(0.94%)
As of 1:35:18 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AULIN SHERRY Chief Financial Officer | Sale | Dec 18, 2024 | 0 |
| AZAB MOHAMMAD Director | Conversion of Exercise of derivative security | Dec 19, 2023 | 74,225 |
| GANNON STEVEN Director | Sale | Mar 7, 2024 | 2,000 |
| GAROFALO ELIZABETH A. Director | Sale | Mar 8, 2024 | 0 |
| KENNEY CHRISTOPHER JOHN Officer | Sale | Mar 24, 2023 | 0 |
| MORTIMER IAN C Chief Executive Officer | Sale | Jan 27, 2025 | 45,602 |
| PATOU GARY Director | Sale | Nov 22, 2024 | 28,475 |
| PIMSTONE SIMON NEIL Director | Sale | Jun 1, 2023 | 6,000 |
| SHERRINGTON ROBIN PAUL Officer | Sale | Mar 7, 2024 | 8,398 |
| SVORONOS DAWN A Director | Sale | Aug 24, 2023 | 25,000 |
Related Tickers
CRNX Crinetics Pharmaceuticals, Inc.
33.40
-1.94%
PTGX Protagonist Therapeutics, Inc.
38.12
-1.40%
ACLX Arcellx, Inc.
67.62
+3.02%
SRRK Scholar Rock Holding Corporation
36.25
-2.27%
BPMC Blueprint Medicines Corporation
89.06
-0.35%
CYTK Cytokinetics, Incorporated
42.76
-2.13%
JANX Janux Therapeutics, Inc.
30.14
+0.50%
KYMR Kymera Therapeutics, Inc.
30.66
-0.07%
MLTX MoonLake Immunotherapeutics
40.04
-0.65%
EWTX Edgewise Therapeutics, Inc.
25.30
+3.27%